This report describes and explains the smart life sciences manufacturing market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global smart life sciences manufacturing market reached a value of nearly $28.75 billion in 2025, having grown at a compound annual growth rate (CAGR) of 15.1% since 2020. The market is expected to grow from $28.75 billion in 2025 to $57.35 billion in 2030 at a rate of 14.8%. The market is then expected to grow at a CAGR of 13.9% from 2030 and reach $110.04 billion in 2035.
Growth in the historic period resulted from rising adoption of personalized medicine, rising research and development spending in the life sciences industry, expansion of smart factories in the pharmaceutical and biotechnology sectors and rising government support towards digital transformation across the life sciences industry. Factors that negatively affected growth in the historic period were high initial capital investment and data security and privacy concerns.
Going forward, expansion of the pharmaceutical sector, increasing adoption of pharma 4 technologies, growth in biopharmaceutical and biologics production and expansion of vaccine manufacturing capacity globally will drive the growth. Factors that could hinder the growth of the smart life sciences manufacturing market in the future include complex regulatory compliance, interoperability issues and impact of trade wars and tariffs.
Market trends for the smart life sciences manufacturing market include integrating artificial intelligence (AI) and autonomous intelligence technologies; integrating Industry 4.0 technologies, intelligent automation, and advanced data analytics; leveraging Internet of Things (IoT), smart infrastructure, and connected ecosystems; integrating digitalization, cloud computing, big data analytics, and advanced cybersecurity; and integrating biotechnology, genomics, and precision medicine approaches.
The smart life sciences manufacturing market is segmented by component into solution and services. The solution market was the largest segment of the smart life sciences manufacturing market segmented by component, accounting for 67.8% or $19.5 billion of the total in 2025. Going forward, the services segment is expected to be the fastest-growing segment in the smart life sciences manufacturing market segmented by component, at a CAGR of 15.2% during 2025-2030.
The smart life sciences manufacturing market is segmented by technology into internet of things (IoT), artificial intelligence, cybersecurity, big data and other technologies. The internet of things (IoT) was the largest segment of the smart life sciences manufacturing market segmented by technology, accounting for 34.9% or $10.04 billion of the total in 2025. Going forward, the artificial intelligence segment is expected to be the fastest-growing segment in the smart life sciences manufacturing market segmented by technology, at a CAGR of 16% during 2025-2030.
The smart life sciences manufacturing market is segmented by application into pharma, bio-pharma and medical device. The pharma market was the largest segment of the smart life sciences manufacturing market segmented by application, accounting for 43.2% or $12.43 billion of the total in 2025. Going forward, the bio-pharma segment is expected to be the fastest-growing segment in the smart life sciences manufacturing market segmented by application, at a CAGR of 16.8% during 2025-2030.
North America was the largest region in the smart life sciences manufacturing market, accounting for 36.1% or $10.37 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the smart life sciences manufacturing market will be Asia Pacific and Eastern Europe where growth will be at CAGRs of 17.2% and 14.8% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 14.6% and 13.5% respectively.
The global smart life sciences manufacturing market is fairly fragmented, with large number of small players operating in the market. The top 10 competitors in the market made up 17.95% of the total market in 2024. Siemens AG was the largest competitor with a 2.06% share of the market, followed ABB Ltd. with 1.96%, Schneider Electric SE with 1.88%, Rockwell Automation Inc. with 1.85%, Honeywell International Inc. with 1.80%, Emerson Electric Co. with 1.76%, SAP SE with 1.71%, Dassault Systemes SE with 1.68%, International Business Machines Corporation with 1.64% and GE Digital (now part of GE Vernova) with 1.61%.
The top opportunities in the smart life sciences manufacturing market segmented by type will arise in the solution segment, which will gain $19.08 billion of global annual sales by 2030. The top opportunities in the smart life sciences manufacturing market segmented by sales channel will arise in the internet of things (IoT) segment, which will gain $9.77 billion of global annual sales by 2030. The top opportunities in the smart life sciences manufacturing market segmented by application will arise in the pharma segment, which will gain $11.59 billion of global annual sales by 2030. The smart life sciences manufacturing market size will gain the most in the USA at $8.27 billion.
Player-adopted strategies in the smart life sciences manufacturing market include focus on strategic partnerships to expand their business expertise, focus on strengthening its business operations through strategic partnerships and focus on strengthening its market position through new launches.
Market-trend-based strategies for the smart life sciences manufacturing market include focus on developing innovative solutions, such as physical AI platforms for biomanufacturing, focus on developing innovative platforms, such as advanced manufacturing execution systems (MES), focus on developing innovative platforms, such as AI-assisted, cloud-native platforms, focus on developing technologically advanced solutions, such as AI enabled validation and process lifecycle platforms.
To take advantage of the opportunities, the analyst recommends the smart life sciences manufacturing companies to focus on physical ai integration in smart biomanufacturing, focus on advanced mes platforms for scalable compliant life sciences manufacturing, focus on ai-assisted cloud-native platforms for compliant and scalable life sciences manufacturing, focus on ai enabled validation platforms for integrated manufacturing efficiency, focus on services-led expansion in smart life sciences manufacturing, expand in emerging markets, continue to focus on developed markets, focus on distribution network expansion and localized channel integration, focus on value-based and tiered pricing for smart life sciences manufacturing, focus on digital and scientific promotion channels, focus on kol partnerships and industry events promotion, focus on workforce capability and bio-pharma engagement in smart life sciences manufacturing.
This product will be delivered within 3-5 business days.
The global smart life sciences manufacturing market reached a value of nearly $28.75 billion in 2025, having grown at a compound annual growth rate (CAGR) of 15.1% since 2020. The market is expected to grow from $28.75 billion in 2025 to $57.35 billion in 2030 at a rate of 14.8%. The market is then expected to grow at a CAGR of 13.9% from 2030 and reach $110.04 billion in 2035.
Growth in the historic period resulted from rising adoption of personalized medicine, rising research and development spending in the life sciences industry, expansion of smart factories in the pharmaceutical and biotechnology sectors and rising government support towards digital transformation across the life sciences industry. Factors that negatively affected growth in the historic period were high initial capital investment and data security and privacy concerns.
Going forward, expansion of the pharmaceutical sector, increasing adoption of pharma 4 technologies, growth in biopharmaceutical and biologics production and expansion of vaccine manufacturing capacity globally will drive the growth. Factors that could hinder the growth of the smart life sciences manufacturing market in the future include complex regulatory compliance, interoperability issues and impact of trade wars and tariffs.
Market trends for the smart life sciences manufacturing market include integrating artificial intelligence (AI) and autonomous intelligence technologies; integrating Industry 4.0 technologies, intelligent automation, and advanced data analytics; leveraging Internet of Things (IoT), smart infrastructure, and connected ecosystems; integrating digitalization, cloud computing, big data analytics, and advanced cybersecurity; and integrating biotechnology, genomics, and precision medicine approaches.
The smart life sciences manufacturing market is segmented by component into solution and services. The solution market was the largest segment of the smart life sciences manufacturing market segmented by component, accounting for 67.8% or $19.5 billion of the total in 2025. Going forward, the services segment is expected to be the fastest-growing segment in the smart life sciences manufacturing market segmented by component, at a CAGR of 15.2% during 2025-2030.
The smart life sciences manufacturing market is segmented by technology into internet of things (IoT), artificial intelligence, cybersecurity, big data and other technologies. The internet of things (IoT) was the largest segment of the smart life sciences manufacturing market segmented by technology, accounting for 34.9% or $10.04 billion of the total in 2025. Going forward, the artificial intelligence segment is expected to be the fastest-growing segment in the smart life sciences manufacturing market segmented by technology, at a CAGR of 16% during 2025-2030.
The smart life sciences manufacturing market is segmented by application into pharma, bio-pharma and medical device. The pharma market was the largest segment of the smart life sciences manufacturing market segmented by application, accounting for 43.2% or $12.43 billion of the total in 2025. Going forward, the bio-pharma segment is expected to be the fastest-growing segment in the smart life sciences manufacturing market segmented by application, at a CAGR of 16.8% during 2025-2030.
North America was the largest region in the smart life sciences manufacturing market, accounting for 36.1% or $10.37 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the smart life sciences manufacturing market will be Asia Pacific and Eastern Europe where growth will be at CAGRs of 17.2% and 14.8% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 14.6% and 13.5% respectively.
The global smart life sciences manufacturing market is fairly fragmented, with large number of small players operating in the market. The top 10 competitors in the market made up 17.95% of the total market in 2024. Siemens AG was the largest competitor with a 2.06% share of the market, followed ABB Ltd. with 1.96%, Schneider Electric SE with 1.88%, Rockwell Automation Inc. with 1.85%, Honeywell International Inc. with 1.80%, Emerson Electric Co. with 1.76%, SAP SE with 1.71%, Dassault Systemes SE with 1.68%, International Business Machines Corporation with 1.64% and GE Digital (now part of GE Vernova) with 1.61%.
The top opportunities in the smart life sciences manufacturing market segmented by type will arise in the solution segment, which will gain $19.08 billion of global annual sales by 2030. The top opportunities in the smart life sciences manufacturing market segmented by sales channel will arise in the internet of things (IoT) segment, which will gain $9.77 billion of global annual sales by 2030. The top opportunities in the smart life sciences manufacturing market segmented by application will arise in the pharma segment, which will gain $11.59 billion of global annual sales by 2030. The smart life sciences manufacturing market size will gain the most in the USA at $8.27 billion.
Player-adopted strategies in the smart life sciences manufacturing market include focus on strategic partnerships to expand their business expertise, focus on strengthening its business operations through strategic partnerships and focus on strengthening its market position through new launches.
Market-trend-based strategies for the smart life sciences manufacturing market include focus on developing innovative solutions, such as physical AI platforms for biomanufacturing, focus on developing innovative platforms, such as advanced manufacturing execution systems (MES), focus on developing innovative platforms, such as AI-assisted, cloud-native platforms, focus on developing technologically advanced solutions, such as AI enabled validation and process lifecycle platforms.
To take advantage of the opportunities, the analyst recommends the smart life sciences manufacturing companies to focus on physical ai integration in smart biomanufacturing, focus on advanced mes platforms for scalable compliant life sciences manufacturing, focus on ai-assisted cloud-native platforms for compliant and scalable life sciences manufacturing, focus on ai enabled validation platforms for integrated manufacturing efficiency, focus on services-led expansion in smart life sciences manufacturing, expand in emerging markets, continue to focus on developed markets, focus on distribution network expansion and localized channel integration, focus on value-based and tiered pricing for smart life sciences manufacturing, focus on digital and scientific promotion channels, focus on kol partnerships and industry events promotion, focus on workforce capability and bio-pharma engagement in smart life sciences manufacturing.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
8 Global Smart Life Sciences Manufacturing Market Attractiveness Scoring and Analysis
9 Major Market Trends
10 Global Smart Life Sciences Manufacturing Growth Analysis and Strategic Analysis Framework
11 Global Smart Life Sciences Manufacturing Market Size and Growth Analysis
12 Global Smart Life Sciences Manufacturing Total Addressable Market (TAM) Analysis
13 Global Smart Life Sciences Manufacturing Market Segmentation
14 Smart Life Sciences Manufacturing Market, Regional and Country Analysis
15 Asia-Pacific Market
16 South East Asia Market
17 North America Market
18 Western Europe Market
19 South America Market
20 Eastern Europe Market
21 Middle East Market
22 Africa Market
23 Competitive Landscape and Company Profiles
24 Other Major and Innovative Companies
27 Smart Life Sciences Manufacturing Market - Company Scoring Matrix
29 Key Mergers and Acquisitions
30 Recent Developments
31 Opportunities and Strategies
32 Smart Life Sciences Manufacturing Market, Conclusions and Recommendations
33 Appendix
Executive Summary
Smart Life Sciences Manufacturing Global Market Opportunities and Strategies to 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global smart life sciences manufacturing market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for smart life sciences manufacturing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The smart life sciences manufacturing market global report answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider smart life sciences manufacturing; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products and supply chain.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
- Growth Analysis and Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional and Country Analysis - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by offering, by technology, by deployment, by application and by industry in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size and Growth - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Recent Developments Information on recent developments in the market covered in the report.
-Market Opportunities and Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations - This section includes recommendations for smart life sciences manufacturing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Component: Solution; Services
2) By Technology: Internet of Things (IoT); Artificial Intelligence; Cybersecurity; Big Data; Other Technologies
3) By Application: Pharma; Bio-Pharma; Medical Device' Other Applications
Companies Mentioned: Siemens AG; ABB Ltd.; Schneider Electric SE; Rockwell Automation Inc.; Honeywell International Inc.
Countries: China; Australia; India; Indonesia; Taiwan; Japan; South Korea; USA; Germany; Italy; Spain; UK; France; Russia
Regions: Asia-Pacific; Western Europe; South East Asia; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; smart life sciences manufacturing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Siemens AG
- ABB Ltd.
- Schneider Electric SE
- Rockwell Automation Inc.
- Honeywell International Inc.
- Emerson Electric Co.
- SAP SE
- Dassault Systemes SE
- International Business Machines Corporation
- GE Digital (now part of GE Vernova)
- Nukon Pty Ltd
- TilliT Pty Ltd
- Infodot Pty Ltd
- CSL Limited
- KPMG China
- WuXi Biologics
- WuXi AppTec
- GenScript Biotech Corporation
- Innovent Biologics
- OMRON Corporation
- Serum Institute of India Pvt. Ltd.
- Bio Farma
- Kalbe Farma
- Dexa Medica
- Indofarma
- Takeda Pharmaceutical Company Limited
- Cellares Corporation
- Astellas Pharma Inc.
- Daiichi Sankyo Company, Limited
- Chugai Pharmaceutical Co., Ltd.
- Celonis SE
- Samsung Biologics Co., Ltd.
- Celltrion
- SK Bioscience
- Lotte Biologics
- Taiwan Bio-Manufacturing Corporation (TBMC)
- PharmaEssentia Corporation
- ScinoPharm Taiwan Ltd.
- EirGenix, Inc.
- Menicon Malaysia Sdn. Bhd.
- Esco Lifesciences Group Ltd.
- MiRXES Pte. Ltd.
- Thermo Fisher Scientific
- Catalent, Inc.
- AGC Biologics
- Bristol Myers Squibb
- Eli Lilly and Company
- Amgen Inc.
- Gilead Sciences, Inc.
- Biogen Inc.
- OmniaBio Inc.
- BIOVECTRA Inc.
- Biodextris Inc.
- AbCellera Biologics Inc.
- Aspect Biosystems
- Sanofi S.A.
- GlaxoSmithKline plc
- AstraZeneca plc
- Boehringer Ingelheim
- Bosch Rexroth
- Cognizant Technology Solutions
- Pfizer Inc.
- Johnson & Johnson
- Novartis AG
- Bayer AG
- F. Hoffmann-La Roche AG
- Teva Pharmaceutical Industries Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 361 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 28.75 Billion |
| Forecasted Market Value ( USD | $ 110.04 Billion |
| Compound Annual Growth Rate | 14.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 67 |
